Related Experiment Video
Updated: Feb 28, 2026
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
In Molecular Pursuit of Bone Metastasis by Fluciclovine PET
1Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Abstract:
Diagnosing bone metastases with traditional anatomic modalities, such as MRI and CT, is limited by sensitivity, and conventional bone radiotracers are only indirect markers of cancer activity. Fortunately, molecular imaging is uniquely capable of providing radiotracers such as fluciclovine and radiolabeled choline, that actually target tumors in the bone. The merits of research in imaging osseous metastases in animal models using these radiotracers and the implications for future clinical translation are discussed.
Insights
Molecular imaging with radiotracers like fluciclovine and radiolabeled choline offers a direct way to detect bone metastases. Research in animal models shows promise for improving diagnosis and future clinical applications.
Area of Science:
- Oncology
- Radiology
- Molecular Imaging
Background:
- Traditional methods like MRI and CT have limited sensitivity for diagnosing bone metastases.
- Conventional bone radiotracers indirectly indicate cancer activity, not tumor presence.
